ThunderBio Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Series B3

  • Latest Deal Amount
  • $17.7M

  • Investors
  • 16

ThunderBio General Information

Description

Manufacturer of digital PCR diagnostic systems designed to focus on the microfluidic technology in vitro diagnostic platforms. The PCR system can digitize the medical test results, and the results can be used for medication guidance or predictive treatment, etc, providing reliable digital support for medical practitioners and researchers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Floors 6 and 7 of Building 6 and Floors 6 and 7 of Building 8, Number 313 Lingxiu Road
  • Luoxing Street, Jiashan County
  • Jiaxing, Zhejiang 314100
  • China
+86 153
Primary Industry
Diagnostic Equipment
Other Industries
Discovery Tools (Healthcare)
Corporate Office
  • Floors 6 and 7 of Building 6 and Floors 6 and 7 of Building 8, Number 313 Lingxiu Road
  • Luoxing Street, Jiashan County
  • Jiaxing, Zhejiang 314100
  • China
+86 153

ThunderBio Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ThunderBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series B3) 15-Jun-2026 $17.7M Completed Generating Revenue
7. Later Stage VC (Series B2) 10-Oct-2025 Completed Generating Revenue
6. Later Stage VC (Series B1) 02-Jan-2024 Completed Generating Revenue
5. Later Stage VC 23-Sep-2022 Completed Generating Revenue
4. Early Stage VC (Series A) 30-Aug-2021 Completed Generating Revenue
3. Early Stage VC 27-Mar-2020 Completed Generating Revenue
2. Seed Round 01-Mar-2019 Completed Startup
1. Accelerator/Incubator 04-Jun-2018 Completed Startup
To view ThunderBio’s complete valuation and funding history, request access »

ThunderBio Patents

ThunderBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D1129670-S1 Droplet microfluidic analyzer Active 09-May-2024
WO-2021147873-A1 Method for amplifying a target nucleic acid Inactive 21-Jan-2020
WO-2020078367-A1 Pressure insensitive microfluidic circuit for droplet generation and uses thereof Inactive 18-Oct-2018
WO-2020057531-A1 Real-time monitoring of single cell or events Inactive 20-Sep-2018
WO-2020043036-A1 Co-detection and digital quantification of bioassay Inactive 27-Aug-2018 C12Q1/6806
To view ThunderBio’s complete patent history, request access »

ThunderBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ThunderBio Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hiway Capital Venture Capital Minority
Shanghai Pudong Venture Capital Venture Capital Minority
Shenzhen Nanshan Strategic Emerging Industry Investment Government Minority
Shanghai STVC Group Growth/Expansion Minority
BridgeOne Capital Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

ThunderBio FAQs

  • When was ThunderBio founded?

    ThunderBio was founded in 2018.

  • Where is ThunderBio headquartered?

    ThunderBio is headquartered in Jiaxing, China.

  • What is the size of ThunderBio?

    ThunderBio has 14 total employees.

  • What industry is ThunderBio in?

    ThunderBio’s primary industry is Diagnostic Equipment.

  • Is ThunderBio a private or public company?

    ThunderBio is a Private company.

  • What is ThunderBio’s current revenue?

    The current revenue for ThunderBio is .

  • How much funding has ThunderBio raised over time?

    ThunderBio has raised $37.5M.

  • Who are ThunderBio’s investors?

    Hiway Capital, Shanghai Pudong Venture Capital, Shenzhen Nanshan Strategic Emerging Industry Investment, Shanghai STVC Group, and BridgeOne Capital are 5 of 16 investors who have invested in ThunderBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process